Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,558 clinical trials
Q Qingqing Cai, MD

A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma

The study is being conducted to evaluate the safety and tolerability of SHR-3079, and to explore the Dose-limiting Toxicity (DLT), Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D). This study also preliminarily evaluated the efficacy of SHR-3079 in patients with B-cell non-Hodgkin lymphoma.

18 years of age All Phase 1

Study to Evaluate a New Cartilage Regeneration Platform for Knee Cartilage Repair

The goal of this clinical trial is to learn if a new treatment works to help regrow knee cartilage in people with knee cartilage damage. The main questions it aims to answer are: Does the treatment help the knee work better and lower pain more than the standard surgery? Is …

19 - 64 years of age All Phase 4

A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)

Researchers are looking for new weight loss medicines for people with higher body weight. The trial medicine, MK-4082, is different from similar weight loss medicines because people take it as a pill instead of an injection. Before giving a trial medicine to participants with a health condition, researchers first do …

18 - 55 years of age All Phase 1
X Xiaodong Zhao

Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

The study is to evaluate the accuracy and safety of a real-time CGM system among adult patients with type 1 diabetes with respect to reference venous plasma sample measurements.

18 years of age All Phase N/A
C Climb Bio Investigative Site 1

A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that selectively binds to CD19 and is projected to deplete targeted cells through antibody-dependent cellular cytotoxicity. This Phase 1b/2a, open-label study will evaluate budoprutug in ascending dose cohorts of patients aged 18 years and above with active, seropositive SLE and inadequate …

18 - 65 years of age All Phase 1/2

Evaluating the Effectiveness of a Colonoscopy Surveillance Recommendations Algorithm in Clinical Practice

The primary objective is to determine if the use of the colonoscopy surveillance recommendations algorithm increases the accuracy of surveillance timing recommendations compared to traditional methods. The secondary objective is to assess the time required to make surveillance recommendations with and without the algorithm, determine the efficiency gains (the average …

18 years of age All Phase N/A

A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969

This is a single center, phase 1, randomized, double-blind, placebo-controlled sequential study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending oral doses of ISM8969 in healthy adults and elderly participants and obese adult participants at risk of cardiovascular disease.

18 - 80 years of age All Phase 1
G Gabriella Mace

A Study of Psychedelics in Healthy Older Adults With Low Well-being

This study is being conducted to understand changes in brain activity following administration of two different drugs (Psilocybin and Dextromethorphan) in older adults with low well-being. The main questions it aims to answer are, does psilocybin: Acutely increase complexity of EEG activity in older adults with low well-being, as modulated …

50 - 85 years of age All Phase 1
D Devanand Anantham

Doctor-patient Partnerships: the Key to a Better Standard of Medical Advice?

Background: The current legal standard of advice in Singapore has three components: distinction of advice from the other parts of clinical consultation (i.e. diagnosis and treatment) for the purpose of standard setting, categories of information that need to be disclosed to patients and how the adequacy of this information is …

21 - 99 years of age All Phase N/A
S Sean Harrington

DElirium and LIGHT: Exploring Modifiable Risk Factors of Delirium - a Pilot Study

After a period of critical illness many people develop problems with memory, attention and thinking and this can make daily life more difficult. A risk factor for these problems is delirium. Delirium is a sudden change in the brain that causes confusion and difficulty focusing. People develop delirium when they …

50 years of age All Phase N/A

Simplify language using AI